Xinxin Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xinxin Hu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Juntao Zhang
The Affiliated People's Hospital of Ningbo University, Ningbo, China; Ningbo Clinical Research Center for Ophthalmology, Ningbo, China; Ningbo Key Laboratory for neuroretinopathy medical Research, Ningbo, China; Department of Ophthalmology, Eye Hospital of Wenzhou Medical University, Ningbo Branch, Ningbo, China
4 shared publicationsDandan Wang
The Affiliated People's Hospital of Ningbo University, Ningbo, China; Ningbo Clinical Research Center for Ophthalmology, Ningbo, China; Ningbo Key Laboratory for neuroretinopathy medical Research, Ningbo, China; Department of Ophthalmology, Eye Hospital of Wenzhou Medical University, Ningbo Branch, Ningbo, China
3 shared publicationsLifang Zhang
The Affiliated People's Hospital of Ningbo University, Ningbo, China; Ningbo Clinical Research Center for Ophthalmology, Ningbo, China; Ningbo Key Laboratory for neuroretinopathy medical Research, Ningbo, China; Department of Ophthalmology, Eye Hospital of Wenzhou Medical University, Ningbo Branch, Ningbo, China
3 shared publicationsNa Zhao
The Affiliated People's Hospital of Ningbo University, Ningbo, China; Ningbo Clinical Research Center for Ophthalmology, Ningbo, China; Ningbo Key Laboratory for neuroretinopathy medical Research, Ningbo, China; Department of Ophthalmology, Eye Hospital of Wenzhou Medical University, Ningbo Branch, Ningbo, China
3 shared publicationsHaixia Ma
Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, Zhejiang, China
2 shared publicationsHengqian He
2 shared publications
Latest Publications
- 7 April 2026
- Published by Elsevier in Sleep Medicine
- Vol. 144, 108955
OCTA-based evaluation of retinal microvascular and structural changes in patients with obstructive sleep apnea–hypopnea syndrome before and after treatment
- 7 April 2026
- Published by Elsevier in Sleep Medicine
- Vol. 144, 108955
OCTA-based evaluation of retinal microvascular and structural changes in patients with obstructive sleep apnea–hypopnea syndrome before and after treatment
- Open Access
- 20 January 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 10790-10791
Letter to the editor regarding “Inhibition of Mettl3-mediated m6A RNA modification of HMGCS1 protects retinal ganglion cells from glutamate excitotoxicity-induced ferroptosis in a rat model of glaucoma”
- 20 January 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 10790-10791
Open AccessLetter to the editor regarding “Inhibition of Mettl3-mediated m6A RNA modification of HMGCS1 protects retinal ganglion cells from glutamate excitotoxicity-induced ferroptosis in a rat model of glaucoma”
- Open Access
- 21 August 2025
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 10 (1) , e002126
Fucoxanthin protects retinal ganglion cells and regulates Parkin-mediated mitophagy in experimental glaucoma
Objective: Glaucoma is a common neurodegenerative disease resulting in irreversible blindness. This study investigates whether fucoxanthin can safeguard retinal ganglion cells (RGCs) by modulating Parkin-mediated mitophagy in experimental glaucoma. Methods: An experimental glaucomatous model was induced in Sprague-Dawley rats via translimbal laser photocoagulation. Intraocular pressure (IOP) was monitored using a Tonolab tonometer. RGC survival was evaluated through FluoroGold labelling. Retinal and optic nerve samples were analysed at 3 days and 2 weeks post-IOP elevation for mitochondrial morphology and gene/protein expression using immunohistochemistry and molecular assays. Results: Results demonstrated that mitophagy was acutely overactivated in the short term and impaired over the long term in ocular hypertensive rats. Fucoxanthin intravitreal administration enhanced RGC survival and Bcl-2 expression while reducing Bax and glial fibrillar acidic protein levels. During acute IOP elevation, fucoxanthin curtailed Parkin expression and mitophagosome formation, mitigating excessive mitophagy. Under prolonged IOP elevation, it elevated mitophagy-related proteins and restored mitophagy function, contributing to damaged mitochondrial clearance. Conclusion: Fucoxanthin exerts neuroprotective effects in experimental glaucoma by modulating Parkin-mediated mitophagy. This highlights the therapeutic potential of maintaining mitophagy homeostasis for glaucoma treatment.
- 21 August 2025
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 10 (1) , e002126
Open AccessFucoxanthin protects retinal ganglion cells and regulates Parkin-mediated mitophagy in experimental glaucoma
Objective: Glaucoma is a common neurodegenerative disease resulting in irreversible blindness. This study investigates whether fucoxanthin can safeguard retinal ganglion cells (RGCs) by modulating Parkin-mediated mitophagy in experimental glaucoma. Methods: An experimental glaucomatous model was induced in Sprague-Dawley rats via translimbal laser photocoagulation. Intraocular pressure (IOP) was monitored using a Tonolab tonometer. RGC survival was evaluated through FluoroGold labelling. Retinal and optic nerve samples were analysed at 3 days and 2 weeks post-IOP elevation for mitochondrial morphology and gene/protein expression using immunohistochemistry and molecular assays. Results: Results demonstrated that mitophagy was acutely overactivated in the short term and impaired over the long term in ocular hypertensive rats. Fucoxanthin intravitreal administration enhanced RGC survival and Bcl-2 expression while reducing Bax and glial fibrillar acidic protein levels. During acute IOP elevation, fucoxanthin curtailed Parkin expression and mitophagosome formation, mitigating excessive mitophagy. Under prolonged IOP elevation, it elevated mitophagy-related proteins and restored mitophagy function, contributing to damaged mitochondrial clearance. Conclusion: Fucoxanthin exerts neuroprotective effects in experimental glaucoma by modulating Parkin-mediated mitophagy. This highlights the therapeutic potential of maintaining mitophagy homeostasis for glaucoma treatment.
- 8 May 2025
- Published by Elsevier in Next Research
- Vol. 2 (3)
Research progress on transcriptomics in aqueous humor and anterior capsule membranes of glaucoma
- 8 May 2025
- Published by Elsevier in Next Research
- Vol. 2 (3)
Research progress on transcriptomics in aqueous humor and anterior capsule membranes of glaucoma
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 34 (7) , 385-394
Fucoxanthin protects retinal ganglion cells and promotes parkin-mediated mitophagy against glutamate excitotoxicity
Objective: To clarify whether fucoxanthin plays a protective role and regulates parkin-mediated mitophagy on retinal ganglion cells (RGCs) against glutamate excitotoxicity. Methods: The excitotoxicity model of primary RGCs was carried out with glutamate. Mitochondrial membrane potential was measured by JC-1 kit (Abcam, USA). The apoptotic rate and cytotoxicity were detected by Hoechst staining and lactate dehydrogenase (LDH) kit (Takara, Japan). Mitochondria was assessed by MitoTracker staining and confocal microscopy. The mRNA levels and protein expression levels of Bax, Bcl-2, parkin, optineurin, LC3, and LAMP1 in RGCs were analyzed by quantitative PCR and immunoblotting. Finally, the mitochondrial health score and mitophagy were assessed by transmission electron microscopy. Results: Fucoxanthin increased the mitochondrial membrane potential of RGCs, reduced cytotoxicity, and decreased apoptosis in RGCs under glutamate excitotoxicity. It also enhanced expression levels of parkin, optineurin, and LAMP1, and upgraded the ratio of LC3-II to LC3-I. Meanwhile, fucoxanthin increased LC3 and MitoTracker co-localization staining. In addition, up-regulated mitochondrial health score, and the number of autophagosomes and mitophagosomes were observed in fucoxanthin-treated RGCs under glutamate excitotoxicity. Conclusion: Fucoxanthin may exert its neuroprotective effect on RGCs via promoting parkin-mediated mitophagy under glutamate excitotoxicity. The neuroprotective effect of fucoxanthin in glaucomatous neurodegeneration and ocular diseases characterized by impaired mitophagy warrants further investigation.
- 1 April 2023
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 34 (7) , 385-394
Open AccessFucoxanthin protects retinal ganglion cells and promotes parkin-mediated mitophagy against glutamate excitotoxicity
Objective: To clarify whether fucoxanthin plays a protective role and regulates parkin-mediated mitophagy on retinal ganglion cells (RGCs) against glutamate excitotoxicity. Methods: The excitotoxicity model of primary RGCs was carried out with glutamate. Mitochondrial membrane potential was measured by JC-1 kit (Abcam, USA). The apoptotic rate and cytotoxicity were detected by Hoechst staining and lactate dehydrogenase (LDH) kit (Takara, Japan). Mitochondria was assessed by MitoTracker staining and confocal microscopy. The mRNA levels and protein expression levels of Bax, Bcl-2, parkin, optineurin, LC3, and LAMP1 in RGCs were analyzed by quantitative PCR and immunoblotting. Finally, the mitochondrial health score and mitophagy were assessed by transmission electron microscopy. Results: Fucoxanthin increased the mitochondrial membrane potential of RGCs, reduced cytotoxicity, and decreased apoptosis in RGCs under glutamate excitotoxicity. It also enhanced expression levels of parkin, optineurin, and LAMP1, and upgraded the ratio of LC3-II to LC3-I. Meanwhile, fucoxanthin increased LC3 and MitoTracker co-localization staining. In addition, up-regulated mitochondrial health score, and the number of autophagosomes and mitophagosomes were observed in fucoxanthin-treated RGCs under glutamate excitotoxicity. Conclusion: Fucoxanthin may exert its neuroprotective effect on RGCs via promoting parkin-mediated mitophagy under glutamate excitotoxicity. The neuroprotective effect of fucoxanthin in glaucomatous neurodegeneration and ocular diseases characterized by impaired mitophagy warrants further investigation.